The aim of the Severely Ill Patient Study (SIPS), which started in 2015, was to conduct a comprehensive “Big Data” analysis on severely ill ME/CFS patients in order to begin an exploration to find the molecular basis of ME/CFS.
STUDY HYPOTHESIS AND DESCRIPTION
The hypothesis of the study was that molecular differences would show the strongest signal in severe cases of the illness when compared to healthy controls.
STUDY DESIGN
Using samples of saliva, blood, urine and feces, this big data study examines the following:
The value of a study of this magnitude is that it provides a foundation of invaluable information to generate hypotheses and to develop diagnostics and treatments. Further, all samples from one patient are taken at one point in time, enabling all measurements to reflect exactly what was happening in the body at that one time point. This allows the possibility for the discovery of biomarkers involving the relationships between different body systems that would not ordinarily be found.
Open Medicine Foundation®
29302 Laro Drive, Agoura Hills, CA 91301 USA
Phone: 650-242-8669
Stay Informed
Be the first to hear our research news.
Subscribe Now.